Delivery Order HHSN272201300022I-75N93019F00133
Award Date
7/12/19
Potential Completion Date
7/11/23
Potential Value
$1M
Federal Agency
National Institute of Allergy and Infectious Diseases
Ultimate Awardee
University System Of Maryland
NAICS Category
541712 - Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Baltimore, MD 21201, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
9
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $3,603,949.00 delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to the University of Maryland, Baltimore (UMB) under the Vaccine and Treatment Evaluation Units (VTEU) Indefinite Delivery Vehicle (IDV). The contract supports vaccine and treatment evaluation activities, which is a major program of NIAID. There was no set-aside designation for this award. UMB, the prime contractor, is a leading public research university that...
This is a delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH), a civilian agency. The contract was awarded to the University of Maryland, Baltimore (UMB) on April 10, 2015 and has a ceiling value of $882,112.66. It is a task order under the Vaccine and Treatment Evaluation Units (VTEU) Indefinite Delivery Vehicle (IDV), which allows NIAID to place orders for medical research and services...
The University of Maryland, Baltimore (UMB) was awarded a $991,159.60 delivery order contract by the National Institute of Allergy and Infectious Diseases, a civilian agency under the Department of Health and Human Services. This award falls under the Vaccine and Treatment Evaluation Units (VTEU) Indefinite Delivery/Indefinite Quantity (IDIQ) contract, which supports vaccine treatment and evaluation research. The contract has no set-aside designation. The award provides funding for UMB to...
This is a delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to the University of Maryland, Baltimore (UMB) under the Vaccine and Treatment Evaluation Units (VTEU) contract vehicle. The $212,458 order is for protocol development and implementation under task order HHSN27200008-14-0013.B1C1.0011, with a completion date of July 14, 2021. UMB, a major public research university, is the prime contractor for...
This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a part of the National Institutes of Health (NIH), to the University of Maryland, Baltimore (UMB) as the prime contractor. The $2,752,906.46 contract is for Vaccine Treatment and Evaluation Units (VTEU), a major NIAID program that supports clinical trials and medical research on vaccines and treatments for infectious diseases. The contract is a delivery order under the larger VTEU...
This federal contract award to the University of Maryland, Baltimore (UMB) was made by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), for Vaccine Treatment and Evaluation Units (VTEU). The $910,006.01 contract is a delivery order under the VTEU indefinite delivery vehicle (IDV), which allows NIAID to order various medical research and clinical trial services from UMB as needed. The contract has no set-aside designation. As...
This is a delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to the University of Maryland, Baltimore (UMB) under the Vaccine and Treatment Evaluation Units (VTEU) contract vehicle. The $488,933.02 award is for a cost-reimbursement contract with no fee to support VTEU activities. UMB, a major public research university, is serving as the prime contractor on this task order, which does not have a...
This is a delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, to the University of Maryland, Baltimore (UMB) under the Vaccine and Treatment Evaluation Units (VTEU) indefinite delivery, indefinite quantity (IDIQ) contract. The order is for VTEU protocol development, implementation, and assays under Task Areas B-D, with a period of performance through September 30, 2023 and a ceiling value of...
This is a $11,622,050.85 firm fixed price delivery order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to the University of Maryland, Baltimore (UMB) to perform work under the Vaccine and Treatment Evaluation Units (VTEU) program. The award has no set-aside designation. The VTEU program supports biomedical and public health research initiatives, and this delivery order continues UMB's role in...
This is a delivery order awarded to the University of Maryland, Baltimore (UMB) under the Vaccine and Treatment Evaluation Units (VTEU) contract vehicle, which is managed by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services. The task order, valued at $1,771,855.55, is for vaccine and treatment evaluation protocol development, implementation, and assays, as well as population pharmacokinetic analyses. UMB, as the prime...